133 related articles for article (PubMed ID: 8198031)
1. Effects of bepridil on silent myocardial ischemia and eicosanoid metabolism in chronic stable angina pectoris after healing of myocardial infarction.
Takase B; Kurita A; Hikita H; Uehata A; Nishioka T; Maruyama T; Mizuno K; Nakamura H; Kanda Y
Am J Cardiol; 1994 Jun; 73(15):1063-8. PubMed ID: 8198031
[TBL] [Abstract][Full Text] [Related]
2. Effect of diltiazem on silent ischemic episodes, plasma bradykinin and prostaglandin metabolism.
Takase B; Kurita A; Uehata A; Nisioka T; Maruyama T; Nagayoshi H; Sugahara H; Mizuno K; Nakamura H; Kodaira T
Int J Cardiol; 1992 Nov; 37(2):177-88. PubMed ID: 1452374
[TBL] [Abstract][Full Text] [Related]
3. Change of plasma leukotriene C4 during myocardial ischemia in humans.
Takase B; Kurita A; Maruyama T; Uehata A; Nishioka T; Mizuno K; Nakamura H; Katsura K; Kanda Y
Clin Cardiol; 1996 Mar; 19(3):198-204. PubMed ID: 8674256
[TBL] [Abstract][Full Text] [Related]
4. Effect of carteolol on silent myocardial ischemia, variability in heart rate, and the pain-modulating system.
Takase B; Hikita H; Uehata A; Satomura K; Kurita A; Nakamura H
Am Heart J; 1997 Nov; 134(5 Pt 1):945-54. PubMed ID: 9398108
[TBL] [Abstract][Full Text] [Related]
5. Effect of nipradilol on silent myocardial ischemia and heart rate variability in chronic stable angina.
Takase B; Hikita H; Satomura K; Mastui T; Ohsuzu F; Kurita A
Cardiovasc Drugs Ther; 2002 Jan; 16(1):43-51. PubMed ID: 12085977
[TBL] [Abstract][Full Text] [Related]
6. [Responses of plasma eicosanoids and hemodynamics to myocardial ischemia and the salutary effect of calcium entry blocker].
Takase B
Nihon Ika Daigaku Zasshi; 1990 Feb; 57(1):42-54. PubMed ID: 2329180
[TBL] [Abstract][Full Text] [Related]
7. Effect of nipradilol on silent myocardial ischemia, plasma beta-endorphin, and bradykinin in chronic stable angina.
Takase B; Kurita A; Uehata A; Hikita H; Nishioka T; Mitani H; Satomura K; Mizuno K; Nakamura H
Clin Cardiol; 1996 Jun; 19(6):477-82. PubMed ID: 8790952
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and safety of bepridil and diltiazem in chronic stable angina pectoris refractory to diltiazem. The Bepridil Collaborative Study Group.
Singh BN
Am J Cardiol; 1991 Aug; 68(4):306-12. PubMed ID: 1858672
[TBL] [Abstract][Full Text] [Related]
9. Plasma bradykinin and prostaglandin metabolism and exercise testing in patients with silent myocardial ischemia compared with patients with painful myocardial ischemia.
Kurita A; Takase B; Maruyama T; Uehata A; Nishioka T; Sugawara H; Nagayoshi H; Satomura K; Mizuno K; Nakamura H
Jpn Circ J; 1989 Nov; 53(11):1466-71. PubMed ID: 2621777
[TBL] [Abstract][Full Text] [Related]
10. Effects of bepridil on exercise tolerance in chronic stable angina: a double-blind, randomized, placebo-controlled, crossover trial.
Hill JA; O'Brien JT; Scott E; Conti CR; Pepine CJ
Am J Cardiol; 1984 Mar; 53(6):679-83. PubMed ID: 6367414
[TBL] [Abstract][Full Text] [Related]
11. Increased blood pressure and neural tone in the silent ischemia of hypertension: disparate effects of immediate release nifedipine.
Lee DD; Rigonan K; Dequattro V
J Am Coll Cardiol; 1993 Nov; 22(5):1438-45. PubMed ID: 8227803
[TBL] [Abstract][Full Text] [Related]
12. [Anti-angina effect of the calcium antagonist bepridil in stable angina pectoris].
Schneider W; Mehlhorn C; Kaltenbach M; Bussmann WD
Z Kardiol; 1985 Jun; 74(6):341-7. PubMed ID: 3895761
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of mibefradil compared with amlodipine in suppressing exercise-induced and daily silent ischemia: results of a multicenter, placebo-controlled trial.
Tzivoni D; Kadr H; Braat S; Rutsch W; Ramires JA; Kobrin I
Circulation; 1997 Oct; 96(8):2557-64. PubMed ID: 9355894
[TBL] [Abstract][Full Text] [Related]
14. Bepridil improves left ventricular performance in patients with angina pectoris.
Zusman RM; Higgins J; Christensen D; Boucher CA
J Cardiovasc Pharmacol; 1993 Sep; 22(3):474-80. PubMed ID: 7504141
[TBL] [Abstract][Full Text] [Related]
15. Silent myocardial ischemia in patients with stable coronary artery disease receiving conventional antianginal drug therapy.
Ferreira JF; César LA; Gruppi CJ; Giorgi DM; Hueb WA; Mansur AP; Ramires JA
Arq Bras Cardiol; 2007 Nov; 89(5):283-8, 312-8. PubMed ID: 18066451
[TBL] [Abstract][Full Text] [Related]
16. Antianginal and anti-ischemic effects of mibefradil in the treatment of patients with chronic stable angina pectoris.
Alpert JS; Bakx AL; Braun S; Frishman WH; Schneeweiss A; Tzivoni D; Kobrin I
Am J Cardiol; 1997 Aug; 80(4B):20C-26C. PubMed ID: 9286850
[TBL] [Abstract][Full Text] [Related]
17. Prognostic implications of ambulatory myocardial ischemia and arrhythmias and relations to ischemia on exercise in chronic stable angina pectoris (the Angina Prognosis Study in Stockholm [APSIS]).
Forslund L; Hjemdahl P; Held C; Eriksson SV; Björkander I; Rehnqvist N
Am J Cardiol; 1999 Nov; 84(10):1151-7. PubMed ID: 10569322
[TBL] [Abstract][Full Text] [Related]
18. Comparative antianginal effects of bepridil and propranolol in angina pectoris.
Parker JO; Farrell B
Am J Cardiol; 1986 Sep; 58(6):449-52. PubMed ID: 3529909
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy and concomitant use of bepridil and beta blockers in the management of angina pectoris.
Frishman WH
Am J Cardiol; 1992 Apr; 69(11):50D-55D. PubMed ID: 1553892
[TBL] [Abstract][Full Text] [Related]
20. [Coronary sinus blood thromboxane and prostacyclin in spontaneous myocardial ischemia].
Giorgadze ML; Panchenko EP; Gratsianskiĭ NA; Masenko VA
Kardiologiia; 1991 Aug; 31(8):7-11. PubMed ID: 1795481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
